Navigation Links
Soon to Be Released: Lutronic Announces the MOSAIC eCO2, the World's First 'Smart' Fractional CO2 Laser System for Treating Aesthetic and Dermatological Conditions, Will Soon Be Coming to the U.S. Market for Commercial Use
Date:5/30/2008

rapid recovery are the cornerstones to this vitally important addition to the Lutronic family of medical laser products."

MOSAIC eCO2 is designed to address a broad scope of clinical applications requiring the ablation, vaporization, excision, incision, and coagulation of soft tissue in dermatology and plastic surgery. A wide range of conditions may be treated with the highest degree of efficacy such as total skin resurfacing, treatment of fine wrinkles, rhytids, acne scars, surgical scars, and uneven pigmentation, such as lentigines and dyschromia.

The MOSAIC eCO2 Laser System utilizes a CO2 tube to generate a laser beam with a wavelength of 10.6 um. Taken together with the unique scanner hand piece, the physician can optimize the effect for different applications by controlling the power of the laser pulse and using a different scan pattern.

"The main differentiating feature of the MOSAIC eCO2 system is the 'freedom' it brings to the practitioner as well as to the patient: freedom from inferior fractional laser systems; freedom from painful treatments and questionable results; freedom to self-select depth and density of treatment; and freedom to select Static and Dynamic modes to deliver the very best results possible.

"The ability to combine two operation modes in one delivery system is particularly important when comparing MOSAIC eCO2 to other fractional CO2 lasers," continued Dr. Hwang. "Static mode offers deeper penetration and greater patient comfort, and Dynamic mode is ideal for larger area blending and smoothing. The laser works exceptionally well in medical applications because 10.6 um is near the peak of tissue water absorption, and when water in the tissue absorbs the laser energy, it heats up. This heating causes instantaneous vaporization of the target tissue. This smart system is yet another example of Lutronic's tireless efforts as the vanguard in breakthrough aesthetic and clinical laser technology."

About Lutroni
'/>"/>

SOURCE Lutronic, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New Medicare and Medicaid Data Released: Featuring Up-To-Date Enrollment Trends, State Initiatives, Regional Market Share and Prescription Drug Benefits
2. Lutronic Inc. Announces FDA Clearance of Its Spectra VRM III Q-Switched Nd: Yag Laser System for Treating a Broad Spectrum of Dermatological and Aesthetic Conditions
3. Elbit Imaging Ltd. Announces First Quarter Results for 2008
4. ASTRO announces 2008 gold medalists
5. Alma Lasers Announces FDA Clearance of the Harmony(XL) Multi-Application System at THE Aesthetic Show 2008
6. Darwin Announces Creation of New Health Care and Errors and Omissions Divisions
7. Alseres Pharmaceuticals, Inc. Announces 2008 Annual Stockholders Meeting
8. Ekahau Announces Compatibility With 802.11n
9. Orphan Therapeutics Announces Initiation of Rolling NDA Submission for LUCASSIN(R) (terlipressin) for the Treatment of Hepatorenal Syndrome Type 1
10. DRAXIS Announces Completion of Sale to Jubilant
11. WellPoint Announces Realignment of Operations, Technology and Government Services Unit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... new three-drug combination has shown in a phase 1/2 ... regimen" in the treatment of patients newly diagnosed with ... bone marrow, say researchers from Dana-Farber Cancer Institute. , ... the 66 patients treated with the drug combination in ... good partial response rate" in the phase 2 population, ...
(Date:12/5/2009)... Blood Cancer Is Most Challenging-- ,, PHILADELPHIA ... identified specific genes, dubbed partner genes, that fuse with ... in infants. By more accurately defining specific partner genes, ... from particular treatments. ,, Oncologists also aim to ...
(Date:12/5/2009)... Midbrook,s advanced Technology Center helps companies develop and test their cleaning ... in a variety of industries and solve problems for customers relating ... ... (Vocus) December 5, 2009 -- Midbrook, Inc , a Jackson, ...
(Date:12/4/2009)... Systems (NYSE: VAR ) announced today that its ... of Stockholders for February 11, 2010 with a record date ... the Crowne Plaza Cabana Hotel, 4290 El Camino Real, Palo ... be webcast by Thomson Financial and can be accessed at ...
(Date:12/4/2009)... Holdings, Ltd (NYSE: AWH ) today announced ... Sennott, Executive Vice,President and Chief Corporate Strategy Officer, will ... Conference being held at the Goldman,Sachs Conference Center in ... About Allied World Assurance Company ...
Breaking Medicine News(10 mins):Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2
... MA--The National Institutes of Health (NIH) has awarded one ... 2008 to a team based at Boston University Medical ... (BMC). These awards, together with 12 CTSAs awarded in ... of an NIH effort to build a national consortium ...
... the focus of the Staying Sharp session on June 3 ... recognized series, the program will emphasize successful aging, including how ... future cognitive function; and the importance of clinical trials and ... member Marwan N. Sabbagh will sign copies of his book, ...
... Pa., May 29 The Pennsylvania,Department of Health today ... 31,observance of "World No Tobacco Day," which is designed ... "Exposure to secondhand smoke causes disease and premature death ... Calvin B.,Johnson. "I encourage all Pennsylvania smokers to set ...
... Ensure Patients Receive High-Value Health Care, WASHINGTON, ... care spending and improve the quality of patient ... Insurance Plans (AHIP) was,implemented. PricewaterhouseCoopers reviewed AHIP,s proposals ... fully implemented, the nation,s,total health care expenditures could ...
... Vanessa Carlton to Help ... Cancer Leader, WASHINGTON, May 29 Breast cancer ... Carlton will join Susan G. Komen for the Cure(R) ... activities leading up to the,19th annual Susan G. Komen ...
... Access by Breaking Through Barriers, NEWPORT NEWS, ... Patient Advocate Foundation today announced a strategic,collaboration that ... families,quick access to timely information and specialized patient ... lives of cancer,patients nationwide who are facing access ...
Other Medicine News:Health News:BUMC, BMC receives Clinical and Translational Science Award from NIH 2Health News:AHIP Outlines Plan to Reduce Health Care Costs by $145 Billion 2Health News:AHIP Outlines Plan to Reduce Health Care Costs by $145 Billion 3Health News:AHIP Outlines Plan to Reduce Health Care Costs by $145 Billion 4Health News:Susan G. Komen for the Cure(R) Celebrity Ambassadors to Convene in Nation's Capital to Help Race for the Cure, End Breast Cancer Forever 2Health News:American Cancer Society, Patient Advocate Foundation Announce Free, Personalized Assistance for Cancer Patients 2Health News:American Cancer Society, Patient Advocate Foundation Announce Free, Personalized Assistance for Cancer Patients 3
(Date:12/4/2009)... Calif., Dec. 4 Vermillion, Inc. (VRML) (Pink Sheets: VRMLQ) ... Amended Plan of Reorganization and related amended Disclosure Statement with ... ,, A hearing to consider the adequacy of ... with the hearing on the confirmation of the Plan scheduled ...
(Date:12/4/2009)... Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that ... Principal investigators will discuss the data presentations surrounding carfilzomib ... the 51st American Society of Hematology (ASH) Annual Meeting. ... a.m. ET on Monday, December 7, 2009. The ...
(Date:12/4/2009)... Shared Imaging, LLC, an independent provider of CT, ... hospitals and healthcare providers, is excited to announce ... Ambulatory Health Care, a nationally-recognized, prestigious gold seal ... care. Shared Imaging accreditation is system-wide for its ...
Breaking Medicine Technology:Vermillion Files Amended Plan of Reorganization and Exchanges Debt 2Vermillion Files Amended Plan of Reorganization and Exchanges Debt 3Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2New research program BioInterfaces launched 8742 1New research program BioInterfaces launched 8742 2Quest Diagnostics to Speak at the William Blair 26 Company 29th Annual Growth Stock Conference 48179 1Quest Diagnostics to Speak at the William Blair 26 Company 29th Annual Growth Stock Conference 48179 2Sinovac Begins the Production of Influenza A 28H1N1 29 Vaccine 12524 1Sinovac Begins the Production of Influenza A 28H1N1 29 Vaccine 12524 2Sinovac Begins the Production of Influenza A 28H1N1 29 Vaccine 12524 3
... CAMBRIDGE, Mass., and BERLIN, Sept. 26 ,Genzyme Corporation ... AG, Germany,today announced that the first patient has ... 3 trials examining the safety and efficacy of ... The CARE-MS I trial (Comparison of Alemtuzumab and ...
... 26 Innocoll, Inc., a privately-held,specialty pharmaceutical company, ... clinical development programs and specialty,pharmaceutical operations: - ... in 2007., - GENTAMICIN ... multi-centered clinical trials for the ...
Other Medicine Technology:Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis 2Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis 3Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis 4Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis 5Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis 6Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations 2Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations 3Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations 4Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations 5Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations 6
The Express Plus clinical chemistry analyzer is a fully automated walk away system designed for maximum productivity, convenience and reliability....
Seamlessly integrates with the i2000SR to form a state-of-the-art immunochemistry platform, the ci8200. Flexibility to prioritize STAT, automated rerun/dilution, and reflex testing over routines to e...
... and controls interchangeable with other Roche/Hitachi ... training costs. Consistent patient results throughout ... handling. 70 positions for routine, STAT ... volumes. Intermix sample types. Intermix 5 ...
Modular Pre-Analytics is an integral component of the new modular systems platform which combines pre-analytics, clinical chemistry and immunochemistry....
Medicine Products: